Within an IRI model, EPZ004777, a DOT1L inhibitor, demonstrated the capacity to suppress PI3K/AKT-mediated reactive oxygen species (ROS) production, ultimately mitigating renal fibrosis [33]. Here, AKT1 is linked to renal fibrosis.